Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ekso Bionics Holdings Inc (EKSO)

Ekso Bionics Holdings Inc (EKSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,253
  • Shares Outstanding, K 2,623
  • Annual Sales, $ 17,930 K
  • Annual Income, $ -11,330 K
  • EBIT $ -11 M
  • EBITDA $ -9 M
  • 60-Month Beta 0.82
  • Price/Sales 0.60
  • Price/Cash Flow N/A
  • Price/Book 1.10

Options Overview Details

View History
  • Implied Volatility 0.00% (unch)
  • Historical Volatility 85.23%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,128.49% on 04/04/25
  • IV Low 0.00% on 12/02/25
  • Expected Move (DTE 11) 1.49 (31.92%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 0
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 217
  • Open Int (30-Day) 217
  • Expected Range 3.17 to 6.15

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.21
  • Number of Estimates 1
  • High Estimate -0.21
  • Low Estimate -0.21
  • Prior Year -2.10
  • Growth Rate Est. (year over year) +90.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.50 +26.29%
on 12/04/25
5.49 -19.49%
on 11/12/25
-0.25 (-5.35%)
since 11/07/25
3-Month
3.47 +27.38%
on 09/11/25
5.70 -22.51%
on 09/29/25
+0.30 (+7.28%)
since 09/08/25
52-Week
2.73 +61.90%
on 06/24/25
14.97 -70.48%
on 01/06/25
-5.74 (-56.51%)
since 12/06/24

Most Recent Stories

More News
Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch’s Groundbreaking BalanceTutor™ Rehabilitation System

SAN RAFAEL, Calif. and TNUVOT, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology...

EKSO : 4.42 (+3.03%)
Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules

SAN RAFAEL, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced...

EKSO : 4.42 (+3.03%)
Ekso Bionics: Q3 Earnings Snapshot

Ekso Bionics: Q3 Earnings Snapshot

EKSO : 4.42 (+3.03%)
Ekso Bionics Reports Third Quarter 2025 Financial Results

SAN RAFAEL, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and...

EKSO : 4.42 (+3.03%)
Ekso Bionics: Q2 Earnings Snapshot

Ekso Bionics: Q2 Earnings Snapshot

EKSO : 4.42 (+3.03%)
Ekso Bionics Reports Second Quarter 2025 Financial Results

SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and...

EKSO : 4.42 (+3.03%)
Ekso Bionics to Report Second Quarter 2025 Financial Results on July 28 – Conference Call to Follow

SAN RAFAEL, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...

EKSO : 4.42 (+3.03%)
Virtual eksoUniversity to Support Continuing Education of PTs and PTAs Across the Country

SAN RAFAEL, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and...

EKSO : 4.42 (+3.03%)
Ekso Bionics’ Acceptance into NVIDIA Connect Program Bears Early Fruit

EKSO : 4.42 (+3.03%)
Ekso Bionics Announces New Effective Date of Reverse Stock Split

EKSO : 4.42 (+3.03%)

Business Summary

Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western...

See More

Key Turning Points

3rd Resistance Point 5.06
2nd Resistance Point 4.78
1st Resistance Point 4.54
Last Price 4.42
1st Support Level 4.01
2nd Support Level 3.73
3rd Support Level 3.49

See More

52-Week High 14.97
Fibonacci 61.8% 10.30
Fibonacci 50% 8.85
Fibonacci 38.2% 7.41
Last Price 4.42
52-Week Low 2.73

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar